MISSIONPHARMA A/S: Financial statements 2016
CVR: 26902398
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
MISSIONPHARMA A/S (CVR 26902398) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 762,676,000 and a net result of DKK 78,005,000 compared with DKK 73,845,000 the year before. That is an increase of 1.2% compared with the year before. The profit margin was 10.2%. Equity in the 2016 report amounted to DKK 209,047,000. The solvency ratio was 65%. The company had 57 employees in the financial year.
- Revenue
- DKK 762,676,000
- Gross Profit
- DKK 142,599,000
- Profit/Loss
- DKK 78,005,000
- Equity
- DKK 209,047,000
- Total Assets
- DKK 321,576,000
- Employees
- 57
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 762.7 mio. | 142.6 mio. | 78 mio. | 209 mio. | 57 |
| 2015 | 753.9 mio. | 122.8 mio. | 73.8 mio. | 185.5 mio. | 49 |
| 2014 | 703.8 mio. | 129.5 mio. | 69 mio. | 162.3 mio. | 42 |
| 2013 | 537.9 mio. | 106.1 mio. | 44.1 mio. | 124.4 mio. | 45 |
Official annual report
Find more companies like MISSIONPHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
MISSIONPHARMA A/S has published its annual report for 2015. Revenue came to DKK 753,910,000, and the net result was DKK 73,845,000.
About MISSIONPHARMA A/S
MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jean-Marc Pierre René Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre René Leccia. The company is owned by CFAO HEALTHCARE SA. The company has 67 employees (2026). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.